Lurbinectedin is a chemotherapy drug used to treat certain types of cancer, such as small cell lung cancer. It works by blocking the growth of cancer cells [3]. According to clinical trials, when lurbinectedin is combined with other chemotherapy drugs, such as doxorubicin, it can cause side effects such as nausea, vomiting, and low blood cell counts [2]. In addition, some patients may experience fatigue, loss of appetite, and hair loss [1].

It is important to note that not all patients will experience these side effects, and the severity of the side effects can vary from person to person. Patients should discuss the potential side effects of lurbinectedin and chemotherapy with their doctor before beginning treatment. It is also important to report any side effects to the doctor immediately, as some side effects can be serious and require medical attention.

Sources:
[1] Mayo Clinic. Lurbinectedin Intravenous Route - Side Effects. Retrieved from https://www.mayoclinic.org/drugs-supplements/lurbinectedin-intravenous-route/side-effects/drg-20490804?p=1
[2] National Cancer Institute. Clinical Trial of Lurbinectedin and Doxorubicin for Small Cell Lung Cancer (SCLC) Patients. Retrieved from https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/c82382
[3] DrugPatentWatch. Lurbinectedin. Retrieved from https://www.drugpatentwatch.com/p/tradename/LURBINECTEDIN